Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/WebMD Partnership Is Data-Gathering Opportunity

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal with WebMD enables FDA to reach more consumers though online polling techniques; the agency will also provide videos to the consumer Web site.
Advertisement

Related Content

Wikipedia Drug Searches Spike Following FDA Safety Warnings – NEJM Study
Wikipedia Drug Searches Spike Following FDA Safety Warnings – NEJM Study
Wikipedia Drug Searches Rise Sharply Following FDA Safety Warnings – NEJM Study
FDA Expands Consumer Outreach Through Drugs.Com Partnership
FDA Expands Consumer Outreach Through Drugs.Com Partnership
FDA’s DTC Web Site For Consumers Sparks Congressional Investigations
FDA’s Post-Market Pharmacoepidemiologic Study Guidance Is 3 Years Away
FDA’s Post-Market Pharmacoepidemiologic Study Guidance Is 3 Years Away
Pfizer Gets Access To Physicians’ Online Conversations Through Sermo Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS067176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel